Redcare Pharmacy NV (SHPPF)
USD 135.79
(0.0%)
USD 135.79
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.02 Billion EUR | 40.05% |
| 2022 | 729.47 Million EUR | -6.85% |
| 2021 | 783.07 Million EUR | 45.85% |
| 2020 | 536.9 Million EUR | 25.45% |
| 2019 | 427.98 Million EUR | 22.32% |
| 2018 | 349.89 Million EUR | 17.49% |
| 2017 | 297.8 Million EUR | 147.45% |
| 2016 | 120.35 Million EUR | 181.38% |
| 2015 | 42.77 Million EUR | 44.95% |
| 2014 | 29.5 Million EUR | 14.73% |
| 2013 | 25.72 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.02 Billion EUR | 1.18% |
| 2024 Q1 | 1.01 Billion EUR | -0.82% |
| 2023 Q2 | 1.09 Billion EUR | 44.32% |
| 2023 Q3 | 1.09 Billion EUR | -0.15% |
| 2023 FY | 1.02 Billion EUR | 40.05% |
| 2023 Q1 | 759.95 Million EUR | 4.18% |
| 2023 Q4 | 1.02 Billion EUR | -6.71% |
| 2022 Q1 | 774.61 Million EUR | -1.08% |
| 2022 Q3 | 768.96 Million EUR | -2.32% |
| 2022 FY | 729.47 Million EUR | -6.85% |
| 2022 Q2 | 787.23 Million EUR | 1.63% |
| 2022 Q4 | 729.47 Million EUR | -5.14% |
| 2021 Q3 | 808.74 Million EUR | -1.04% |
| 2021 Q1 | 834.79 Million EUR | 55.48% |
| 2021 FY | 783.07 Million EUR | 45.85% |
| 2021 Q4 | 783.07 Million EUR | -3.17% |
| 2021 Q2 | 817.23 Million EUR | -2.1% |
| 2020 Q2 | 544.87 Million EUR | 16.23% |
| 2020 Q1 | 468.77 Million EUR | 9.53% |
| 2020 FY | 536.9 Million EUR | 25.45% |
| 2020 Q4 | 536.9 Million EUR | -2.36% |
| 2020 Q3 | 549.87 Million EUR | 0.92% |
| 2019 Q2 | 456.01 Million EUR | 28.84% |
| 2019 FY | 427.98 Million EUR | 22.32% |
| 2019 Q4 | 427.98 Million EUR | -5.06% |
| 2019 Q3 | 450.8 Million EUR | -1.14% |
| 2019 Q1 | 353.95 Million EUR | 1.16% |
| 2018 Q4 | 349.89 Million EUR | -3.84% |
| 2018 FY | 349.89 Million EUR | 17.49% |
| 2018 Q1 | 297.15 Million EUR | -0.22% |
| 2018 Q2 | 358.97 Million EUR | 20.8% |
| 2018 Q3 | 363.87 Million EUR | 1.37% |
| 2017 Q3 | 124.61 Million EUR | 9.23% |
| 2017 FY | 297.8 Million EUR | 147.45% |
| 2017 Q4 | 297.8 Million EUR | 138.99% |
| 2017 Q1 | 122.09 Million EUR | 1.45% |
| 2017 Q2 | 114.08 Million EUR | -6.56% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 49.54 Million EUR | 0.0% |
| 2016 Q4 | 120.35 Million EUR | 102.43% |
| 2016 Q3 | 59.45 Million EUR | 20.01% |
| 2016 FY | 120.35 Million EUR | 181.38% |
| 2015 Q4 | 42.77 Million EUR | 0.0% |
| 2015 FY | 42.77 Million EUR | 44.95% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | 29.5 Million EUR | 14.73% |
| 2013 FY | 25.72 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | 220.00 USD | -464361718.182% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | -79.94% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | -97652.525% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 501.27 Thousand USD | -203697.885% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | -31740.24% |
| LIGAND PHARMACEUTICAL INC | 787.21 Million USD | -29.773% |
| MedGen, Inc. | 0.79 USD | -129315949267.089% |
| Omni Health, Inc. | 5.53 Million USD | -18368.45% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | -226377.285% |
| Pineapple, Inc. | 7.83 Million USD | -12931.17% |
| ScripsAmerica, Inc. | 5.64 Million USD | -18000.452% |